Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity

The replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mediated by its main protease (M(pro)), which is a plausible therapeutic target for coronavirus disease 2019 (COVID-19). Although numerous in silico studies reported the potential inhibitory effects of natural pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Puopolo, Tess, Li, Huifang, Cai, Ang, Seeram, Navindra P., Ma, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502466/
https://www.ncbi.nlm.nih.gov/pubmed/36144858
http://dx.doi.org/10.3390/molecules27186127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502466/
https://www.ncbi.nlm.nih.gov/pubmed/36144858
http://dx.doi.org/10.3390/molecules27186127

Ejemplares similares